Tekla Capital Management LLC 89bio, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 105,898 shares of ETNB stock, worth $839,771. This represents 0.08% of its overall portfolio holdings.
Number of Shares
105,898
Previous 105,898
-0.0%
Holding current value
$839,771
Previous $1.61 Million
24.44%
% of portfolio
0.08%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$120 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$112 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$63.4 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$58.5 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$55.6 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $369M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...